Home / News
Dr Lal PathLabs Q2 Profit Jumps 27%, Declares Rs 5 Interim Dividend
• Dr Lal PathLabs reported a 27.4% year-on-year rise in Q2 FY27 consolidated net profit to Rs 193.9 crore from Rs 152 crore.
• Total income grew 20.2% to Rs 908.2 crore; profit before tax rose 27.9% to Rs 260.5 crore.
• The board declared a second interim dividend of Rs 5 per share (50% payout), with record date November 11, 2026.
• For H1 FY27, net profit climbed 27.3% to Rs 364.4 crore on total income of Rs 1,737.8 crore.
Dr Lal PathLabs on Wednesday reported that its consolidated net profit rose 27.4% year-on-year to Rs 193.9 crore for the July-September quarter of FY27, compared with Rs 152 crore a year earlier. Total income grew 20.2% to Rs 908.2 crore from Rs 755.4 crore in the year-ago quarter, while profit before tax increased 27.9% to Rs 260.5 crore from Rs 203.6 crore.
Total expenses rose 17.4% to Rs 647.6 crore from Rs 551.8 crore. Employee benefits expenses increased to Rs 138.6 crore from Rs 123.6 crore, cost of materials consumed stood at Rs 161.9 crore versus Rs 141.8 crore, and fees paid to collection centres and channel partners rose to Rs 128.9 crore from Rs 108.7 crore. Tax expense for the quarter was Rs 66.6 crore, up from Rs 51.4 crore.
The board declared a second interim dividend of Rs 5 per equity share, translating to a 50% payout for FY27. The record date is November 11, 2026, and the dividend will be paid within 30 days of declaration.
For the first half of FY27, revenue from operations rose 19.4% to Rs 1,671.6 crore from Rs 1,400.4 crore, total income increased 19.6% to Rs 1,737.8 crore from Rs 1,453.3 crore, and net profit climbed 27.3% to Rs 364.4 crore from Rs 286.2 crore. The results underscore continued demand for diagnostic services and the company’s ability to expand revenue while containing cost growth.